An indirect comparison of efficacy and safety of elvitegravir/cobicistat/emtricitabine/tenofovir and dolutegravir + abacavir/lamivudine

por Rogatto, Felipe, Bouee, Stephane, Jeanbat, Vivianne, Piontkowsky, David, Aragao, Filipa, Bosse, Matthew
Publicado 2014

877. North American Phase 3/3b Experience with Long-Acting Cabotegravir and Rilpivirine: Efficacy, Safety, and Virologic Outcomes

por Taiwo, Babafemi O, Tan, Darrell, Patel, Parul, Teichner, Paula, Polli, Joseph, Garside, Louise, D’Amico, Ronald, Talarico, Christine L, Van Solingen-Ristea, Rodica, Baugh, Bryan, Spreen, William, Aboud, Michael, Bosse, Matthew
Publicado 2021

885. Pregnancy Outcomes and Pharmacokinetics in Pregnant Women Living with HIV Exposed to Long-Acting Cabotegravir and Rilpivirine in Clinical Trials

por Patel, Parul, Ford, Susan L, Baker, Mark, Meyer, Claudia, Garside, Louise, D’Amico, Ronald, Van Solingen-Ristea, Rodica, Crauwels, Herta, Polli, Joseph, Seal, Ciara, Thiagarajah, Shanker, Birmingham, Eileen, Spreen, William, Baugh, Bryan, Bosse, Matthew, Vannappagari, Vani
Publicado 2021